Trial
NCT03527264
BrUOG 355: Nivolumab to Tailored Radiation Therapy With Concomitant Cisplatin in the Treatment of Patients With Cervical Cancer
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Brown University
Collaborators
Rhode Island Hospital; The Miriam Hospital; Women and Infants Hospital of Rhode Island; Bristol-Myers Squibb
Condition
Cervical Cancer
Intervention
Nivolumab induction
Why stopped
Slow enrollment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-04-04